[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Companion Cancer Diagnostics Market Insights, Forecast to 2029

November 2023 | 94 pages | ID: G25C17681598EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Companion Cancer Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Companion Cancer Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Companion Cancer Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Companion Cancer Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Companion Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Companion Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including F. Hoffmann-La Roche, Agilent Technologies, QIAGEN, Abbott Laboratories, Almac Group, Danaher Corporation, bioMйrieuxSA and Myriad Genetics, etc.

By Company
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • QIAGEN
  • Abbott Laboratories
  • Almac Group
  • Danaher Corporation
  • bioMйrieuxSA
  • Myriad Genetics
Segment by Type
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Gastric Cancer
Segment by Application
  • Pharmaceutical & Biopharmaceutical Companies
  • Reference Laboratories
  • CROs
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East, Africa, and Latin America
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Companion Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Companion Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Companion Cancer Diagnostics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions
1 STUDY COVERAGE

1.1 Stereo Earbuds Product Introduction
1.2 Market by Type
  1.2.1 Global Stereo Earbuds Market Size by Type, 2018 VS 2022 VS 2029
  1.2.2 Normal Earbuds
  1.2.3 Sound Control Earbuds
1.3 Market by Application
  1.3.1 Global Stereo Earbuds Market Size by Application, 2018 VS 2022 VS 2029
  1.3.2 Consumer
  1.3.3 Healthcare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL STEREO EARBUDS PRODUCTION

2.1 Global Stereo Earbuds Production Capacity (2018-2029)
2.2 Global Stereo Earbuds Production by Region: 2018 VS 2022 VS 2029
2.3 Global Stereo Earbuds Production by Region
  2.3.1 Global Stereo Earbuds Historic Production by Region (2018-2023)
  2.3.2 Global Stereo Earbuds Forecasted Production by Region (2024-2029)
  2.3.3 Global Stereo Earbuds Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 South Korea

3 EXECUTIVE SUMMARY

3.1 Global Stereo Earbuds Revenue Estimates and Forecasts 2018-2029
3.2 Global Stereo Earbuds Revenue by Region
  3.2.1 Global Stereo Earbuds Revenue by Region: 2018 VS 2022 VS 2029
  3.2.2 Global Stereo Earbuds Revenue by Region (2018-2023)
  3.2.3 Global Stereo Earbuds Revenue by Region (2024-2029)
  3.2.4 Global Stereo Earbuds Revenue Market Share by Region (2018-2029)
3.3 Global Stereo Earbuds Sales Estimates and Forecasts 2018-2029
3.4 Global Stereo Earbuds Sales by Region
  3.4.1 Global Stereo Earbuds Sales by Region: 2018 VS 2022 VS 2029
  3.4.2 Global Stereo Earbuds Sales by Region (2018-2023)
  3.4.3 Global Stereo Earbuds Sales by Region (2024-2029)
  3.4.4 Global Stereo Earbuds Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America

4 COMPETITION BY MANUFACTURES

4.1 Global Stereo Earbuds Sales by Manufacturers
  4.1.1 Global Stereo Earbuds Sales by Manufacturers (2018-2023)
  4.1.2 Global Stereo Earbuds Sales Market Share by Manufacturers (2018-2023)
  4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Stereo Earbuds in 2022
4.2 Global Stereo Earbuds Revenue by Manufacturers
  4.2.1 Global Stereo Earbuds Revenue by Manufacturers (2018-2023)
  4.2.2 Global Stereo Earbuds Revenue Market Share by Manufacturers (2018-2023)
  4.2.3 Global Top 10 and Top 5 Companies by Stereo Earbuds Revenue in 2022
4.3 Global Stereo Earbuds Sales Price by Manufacturers
4.4 Global Key Players of Stereo Earbuds, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
  4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  4.5.2 Global Stereo Earbuds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Stereo Earbuds, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Stereo Earbuds, Product Offered and Application
4.8 Global Key Manufacturers of Stereo Earbuds, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans

5 MARKET SIZE BY TYPE

5.1 Global Stereo Earbuds Sales by Type
  5.1.1 Global Stereo Earbuds Historical Sales by Type (2018-2023)
  5.1.2 Global Stereo Earbuds Forecasted Sales by Type (2024-2029)
  5.1.3 Global Stereo Earbuds Sales Market Share by Type (2018-2029)
5.2 Global Stereo Earbuds Revenue by Type
  5.2.1 Global Stereo Earbuds Historical Revenue by Type (2018-2023)
  5.2.2 Global Stereo Earbuds Forecasted Revenue by Type (2024-2029)
  5.2.3 Global Stereo Earbuds Revenue Market Share by Type (2018-2029)
5.3 Global Stereo Earbuds Price by Type
  5.3.1 Global Stereo Earbuds Price by Type (2018-2023)
  5.3.2 Global Stereo Earbuds Price Forecast by Type (2024-2029)

6 MARKET SIZE BY APPLICATION

6.1 Global Stereo Earbuds Sales by Application
  6.1.1 Global Stereo Earbuds Historical Sales by Application (2018-2023)
  6.1.2 Global Stereo Earbuds Forecasted Sales by Application (2024-2029)
  6.1.3 Global Stereo Earbuds Sales Market Share by Application (2018-2029)
6.2 Global Stereo Earbuds Revenue by Application
  6.2.1 Global Stereo Earbuds Historical Revenue by Application (2018-2023)
  6.2.2 Global Stereo Earbuds Forecasted Revenue by Application (2024-2029)
  6.2.3 Global Stereo Earbuds Revenue Market Share by Application (2018-2029)
6.3 Global Stereo Earbuds Price by Application
  6.3.1 Global Stereo Earbuds Price by Application (2018-2023)
  6.3.2 Global Stereo Earbuds Price Forecast by Application (2024-2029)

7 US & CANADA

7.1 US & Canada Stereo Earbuds Market Size by Type
  7.1.1 US & Canada Stereo Earbuds Sales by Type (2018-2029)
  7.1.2 US & Canada Stereo Earbuds Revenue by Type (2018-2029)
7.2 US & Canada Stereo Earbuds Market Size by Application
  7.2.1 US & Canada Stereo Earbuds Sales by Application (2018-2029)
  7.2.2 US & Canada Stereo Earbuds Revenue by Application (2018-2029)
7.3 US & Canada Stereo Earbuds Sales by Country
  7.3.1 US & Canada Stereo Earbuds Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 US & Canada Stereo Earbuds Sales by Country (2018-2029)
  7.3.3 US & Canada Stereo Earbuds Revenue by Country (2018-2029)
  7.3.4 U.S.
  7.3.5 Canada

8 EUROPE

8.1 Europe Stereo Earbuds Market Size by Type
  8.1.1 Europe Stereo Earbuds Sales by Type (2018-2029)
  8.1.2 Europe Stereo Earbuds Revenue by Type (2018-2029)
8.2 Europe Stereo Earbuds Market Size by Application
  8.2.1 Europe Stereo Earbuds Sales by Application (2018-2029)
  8.2.2 Europe Stereo Earbuds Revenue by Application (2018-2029)
8.3 Europe Stereo Earbuds Sales by Country
  8.3.1 Europe Stereo Earbuds Revenue by Country: 2018 VS 2022 VS 2029
  8.3.2 Europe Stereo Earbuds Sales by Country (2018-2029)
  8.3.3 Europe Stereo Earbuds Revenue by Country (2018-2029)
  8.3.4 Germany
  8.3.5 France
  8.3.6 U.K.
  8.3.7 Italy
  8.3.8 Russia

9 CHINA

9.1 China Stereo Earbuds Market Size by Type
  9.1.1 China Stereo Earbuds Sales by Type (2018-2029)
  9.1.2 China Stereo Earbuds Revenue by Type (2018-2029)
9.2 China Stereo Earbuds Market Size by Application
  9.2.1 China Stereo Earbuds Sales by Application (2018-2029)
  9.2.2 China Stereo Earbuds Revenue by Application (2018-2029)

10 ASIA (EXCLUDING CHINA)

10.1 Asia Stereo Earbuds Market Size by Type
  10.1.1 Asia Stereo Earbuds Sales by Type (2018-2029)
  10.1.2 Asia Stereo Earbuds Revenue by Type (2018-2029)
10.2 Asia Stereo Earbuds Market Size by Application
  10.2.1 Asia Stereo Earbuds Sales by Application (2018-2029)
  10.2.2 Asia Stereo Earbuds Revenue by Application (2018-2029)
10.3 Asia Stereo Earbuds Sales by Region
  10.3.1 Asia Stereo Earbuds Revenue by Region: 2018 VS 2022 VS 2029
  10.3.2 Asia Stereo Earbuds Revenue by Region (2018-2029)
  10.3.3 Asia Stereo Earbuds Sales by Region (2018-2029)
  10.3.4 Japan
  10.3.5 South Korea
  10.3.6 China Taiwan
  10.3.7 Southeast Asia
  10.3.8 India

11 MIDDLE EAST, AFRICA AND LATIN AMERICA

11.1 Middle East, Africa and Latin America Stereo Earbuds Market Size by Type
  11.1.1 Middle East, Africa and Latin America Stereo Earbuds Sales by Type (2018-2029)
  11.1.2 Middle East, Africa and Latin America Stereo Earbuds Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Stereo Earbuds Market Size by Application
  11.2.1 Middle East, Africa and Latin America Stereo Earbuds Sales by Application (2018-2029)
  11.2.2 Middle East, Africa and Latin America Stereo Earbuds Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Stereo Earbuds Sales by Country
  11.3.1 Middle East, Africa and Latin America Stereo Earbuds Revenue by Country: 2018 VS 2022 VS 2029
  11.3.2 Middle East, Africa and Latin America Stereo Earbuds Revenue by Country (2018-2029)
  11.3.3 Middle East, Africa and Latin America Stereo Earbuds Sales by Country (2018-2029)
  11.3.4 Brazil
  11.3.5 Mexico
  11.3.6 Turkey
  11.3.7 Israel
  11.3.8 GCC Countries

12 CORPORATE PROFILES

12.1 Apple
  12.1.1 Apple Company Information
  12.1.2 Apple Overview
  12.1.3 Apple Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.1.4 Apple Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.1.5 Apple Recent Developments
12.2 Samsung
  12.2.1 Samsung Company Information
  12.2.2 Samsung Overview
  12.2.3 Samsung Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.2.4 Samsung Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.2.5 Samsung Recent Developments
12.3 Sony
  12.3.1 Sony Company Information
  12.3.2 Sony Overview
  12.3.3 Sony Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.3.4 Sony Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.3.5 Sony Recent Developments
12.4 GN(Jabra)
  12.4.1 GN(Jabra) Company Information
  12.4.2 GN(Jabra) Overview
  12.4.3 GN(Jabra) Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.4.4 GN(Jabra) Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.4.5 GN(Jabra) Recent Developments
12.5 Bragi
  12.5.1 Bragi Company Information
  12.5.2 Bragi Overview
  12.5.3 Bragi Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.5.4 Bragi Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.5.5 Bragi Recent Developments
12.6 Doppler Labs
  12.6.1 Doppler Labs Company Information
  12.6.2 Doppler Labs Overview
  12.6.3 Doppler Labs Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.6.4 Doppler Labs Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.6.5 Doppler Labs Recent Developments
12.7 Skybuds
  12.7.1 Skybuds Company Information
  12.7.2 Skybuds Overview
  12.7.3 Skybuds Stereo Earbuds Sales, Price, Revenue and Gross Margin (2018-2023)
  12.7.4 Skybuds Stereo Earbuds Product Model Numbers, Pictures, Descriptions and Specifications
  12.7.5 Skybuds Recent Developments

13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13.1 Stereo Earbuds Industry Chain Analysis
13.2 Stereo Earbuds Key Raw Materials
  13.2.1 Key Raw Materials
  13.2.2 Raw Materials Key Suppliers
13.3 Stereo Earbuds Production Mode & Process
13.4 Stereo Earbuds Sales and Marketing
  13.4.1 Stereo Earbuds Sales Channels
  13.4.2 Stereo Earbuds Distributors
13.5 Stereo Earbuds Customers

14 STEREO EARBUDS MARKET DYNAMICS

14.1 Stereo Earbuds Industry Trends
14.2 Stereo Earbuds Market Drivers
14.3 Stereo Earbuds Market Challenges
14.4 Stereo Earbuds Market Restraints

15 KEY FINDING IN THE GLOBAL STEREO EARBUDS STUDY


16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Companion Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Breast Cancer
Table 3. Key Players of Lung Cancer
Table 4. Key Players of Colorectal Cancer
Table 5. Key Players of Melanoma
Table 6. Key Players of Gastric Cancer
Table 7. Global Companion Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Companion Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Companion Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Companion Cancer Diagnostics Market Share by Region (2018-2023)
Table 11. Global Companion Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Companion Cancer Diagnostics Market Share by Region (2024-2029)
Table 13. Companion Cancer Diagnostics Market Trends
Table 14. Companion Cancer Diagnostics Market Drivers
Table 15. Companion Cancer Diagnostics Market Challenges
Table 16. Companion Cancer Diagnostics Market Restraints
Table 17. Global Companion Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Companion Cancer Diagnostics Revenue Share by Players (2018-2023)
Table 19. Global Top Companion Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Cancer Diagnostics as of 2022)
Table 20. Global Companion Cancer Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Companion Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Companion Cancer Diagnostics, Headquarters and Area Served
Table 23. Global Key Players of Companion Cancer Diagnostics, Product and Application
Table 24. Global Key Players of Companion Cancer Diagnostics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Companion Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Companion Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Companion Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 30. Global Companion Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Companion Cancer Diagnostics Revenue Share by Application (2018-2023)
Table 32. Global Companion Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Companion Cancer Diagnostics Revenue Share by Application (2024-2029)
Table 34. North America Companion Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Companion Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Companion Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Companion Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Companion Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Companion Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Companion Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Companion Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Companion Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Companion Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Companion Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Companion Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Companion Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Companion Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Companion Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Companion Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Companion Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Companion Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Companion Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Companion Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Companion Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Companion Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Companion Cancer Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Companion Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Companion Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Companion Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Companion Cancer Diagnostics Product
Table 69. F. Hoffmann-La Roche Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Agilent Technologies Company Details
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Companion Cancer Diagnostics Product
Table 74. Agilent Technologies Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Agilent Technologies Recent Developments
Table 76. QIAGEN Company Details
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Companion Cancer Diagnostics Product
Table 79. QIAGEN Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 80. QIAGEN Recent Developments
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Companion Cancer Diagnostics Product
Table 84. Abbott Laboratories Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 85. Abbott Laboratories Recent Developments
Table 86. Almac Group Company Details
Table 87. Almac Group Business Overview
Table 88. Almac Group Companion Cancer Diagnostics Product
Table 89. Almac Group Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 90. Almac Group Recent Developments
Table 91. Danaher Corporation Company Details
Table 92. Danaher Corporation Business Overview
Table 93. Danaher Corporation Companion Cancer Diagnostics Product
Table 94. Danaher Corporation Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Danaher Corporation Recent Developments
Table 96. bioMйrieuxSA Company Details
Table 97. bioMйrieuxSA Business Overview
Table 98. bioMйrieuxSA Companion Cancer Diagnostics Product
Table 99. bioMйrieuxSA Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 100. bioMйrieuxSA Recent Developments
Table 101. Myriad Genetics Company Details
Table 102. Myriad Genetics Business Overview
Table 103. Myriad Genetics Companion Cancer Diagnostics Product
Table 104. Myriad Genetics Revenue in Companion Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 105. Myriad Genetics Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Companion Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Companion Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Breast Cancer Features
Figure 4. Lung Cancer Features
Figure 5. Colorectal Cancer Features
Figure 6. Melanoma Features
Figure 7. Gastric Cancer Features
Figure 8. Global Companion Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Companion Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 10. Pharmaceutical & Biopharmaceutical Companies Case Studies
Figure 11. Reference Laboratories Case Studies
Figure 12. CROs Case Studies
Figure 13. Others Case Studies
Figure 14. Companion Cancer Diagnostics Report Years Considered
Figure 15. Global Companion Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Companion Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Companion Cancer Diagnostics Market Share by Region: 2022 VS 2029
Figure 18. Global Companion Cancer Diagnostics Market Share by Players in 2022
Figure 19. Global Top Companion Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Cancer Diagnostics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Companion Cancer Diagnostics Revenue in 2022
Figure 21. North America Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Companion Cancer Diagnostics Market Share by Type (2018-2029)
Figure 23. North America Companion Cancer Diagnostics Market Share by Application (2018-2029)
Figure 24. North America Companion Cancer Diagnostics Market Share by Country (2018-2029)
Figure 25. United States Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Companion Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Companion Cancer Diagnostics Market Share by Type (2018-2029)
Figure 29. Europe Companion Cancer Diagnostics Market Share by Application (2018-2029)
Figure 30. Europe Companion Cancer Diagnostics Market Share by Country (2018-2029)
Figure 31. Germany Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Companion Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Companion Cancer Diagnostics Market Share by Type (2018-2029)
Figure 39. China Companion Cancer Diagnostics Market Share by Application (2018-2029)
Figure 40. Asia Companion Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Companion Cancer Diagnostics Market Share by Type (2018-2029)
Figure 42. Asia Companion Cancer Diagnostics Market Share by Application (2018-2029)
Figure 43. Asia Companion Cancer Diagnostics Market Share by Region (2018-2029)
Figure 44. Japan Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Companion Cancer Diagnostics Market Share by Country (2018-2029)
Figure 54. Brazil Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Companion Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 61. Agilent Technologies Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 62. QIAGEN Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 63. Abbott Laboratories Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 64. Almac Group Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 65. Danaher Corporation Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 66. bioMйrieuxSA Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 67. Myriad Genetics Revenue Growth Rate in Companion Cancer Diagnostics Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


More Publications